768 INDEX. 



PAGE 



422 ; prophylaxis, 422 ; susceptibility, 421 ; symp- 

 toms 419 ; tissues affected by toxin, 421 ; see 

 Bacillus botulinus. 



Bovine pest 26 



Bronchitis. 



In epidemic cerebrospinal meningitis, 559 ; meningo- 

 coccus in, 559 ; Micrococcus catarrhalis in, 551, 559 ; 

 staphylococcus in. 544 ; streptococcus in, 520. 



Capsulated bacilli 571, 572 



Carbuncle, staphylococcus in 543, 544 



Carcinoma, hereditary susceptibility to 130 



Cell receptors ; see Receptors. 



Cercomonas intestinalis , morphology and pathogenicity 



of I 692, 693 



Chancroid ; see soft chancre. 



Chemicals in relation to antibody formatio'n 342 



Chemotaxis 146, 307, 315 



Chicken cholera, attenuation of microbe of 363 



Chicken-pox (varicella ) 743, 744 



Chicken typhus or chicken-pest 26 



Cholera 25, 469-480 



Accidental, in man, 478 ; agglutination reaction, 480 ; 

 animals, susceptibility of, to, 474 ; antibodies, origin 

 of, 320, 479 ; antitoxic serum, 480 ; bactericidal 

 power of body fluids, 478 ; "cholera-carriers," 469, 

 478 ; diagnosis, bacteriologic, 480 ; epidemiology, 

 473, 474, 476, 477 ; experimental, in man, 478 ; gas- 

 tric juice, protective action of, 478 ; geographic dis- 

 tribution of, 473 ; immunity and susceptibility to, 

 161, 169, 320, 478, 479; infection atrium, 472; 

 lesions, intestinal, 475 : effect of leucotoxic serum on 

 infections, 298 ; mechanism of intoxication, 475 ; 

 mixed immunization in, 378, 480 ; phagocytosis, 

 378, 319, 478, 479 ; phagolysis, 318 ; prophylaxis, 

 362, 472, 476 ; serum properties in, 211 ; sero- 

 therapy, 374, 480 ; sources of infection and trans- 

 mission, 472-474 ; vaccines and vaccination, 166, 

 477, 478 ; see Vibrio cholerce. 



Cholesterin, neutralizing action on tetanolysin 204 



Chromophages 309 



Cladothrix, infections with 634 



Clavelee (sheep-pox) 26, 743 



Co-agglutinins 225 



Cobra-lecithid 275 



Cobra venom ; seen Venoms. 



Coccidia, life cycle, morphology, spore formation and 

 pathogenecity, 694, 695. 



Coccidiosis 694, 695 



Coccidium bigeminum 695 



Coccidium cuniculi s. ovi forme 695 



Cocobacteria septica (Billroth) 515 



Coley's mixture 529 



Colle's law ; see Syphilis. 



Colloids 242-244 



Complement. 



Absorption of, 259, 373 ; analysis of. 277 ; decrease of 

 during- disease, 374 ; diversion of. 272, 373, 374 ; 

 inhibition of, 280 ; isolation of, 255 ; lecithin as a, 

 274; multiplicity of. 268, 354; origin of, 253, 310; 

 neutralization of, by salts, 204, 276 ; receptors of 

 second order, 351 ; resistance to heat, 249 ; solu- 

 tions of 258 ; sources of, for bactericidal serums, 



